AAAAAA

   
Results: 1-7 |
Results: 7

Authors: RING BJ CATLOW J LINDSAY TJ GILLESPIE T ROSKOS LK CERIMELE BJ SWANSON SP HAMMAN MA WRIGHTON SA
Citation: Bj. Ring et al., IDENTIFICATION OF THE HUMAN CYTOCHROMES P450 RESPONSIBLE FOR THE IN-VITRO FORMATION OF THE MAJOR OXIDATIVE METABOLITES OF THE ANTIPSYCHOTICAGENT OLANZAPINE, The Journal of pharmacology and experimental therapeutics, 276(2), 1996, pp. 658-666

Authors: SWANSON SP WILHELM WW
Citation: Sp. Swanson et Ww. Wilhelm, PLANTING DATE AND RESIDUE RATE EFFECTS ON GROWTH, PARTITIONING, AND YIELD OF CORN, Agronomy journal, 88(2), 1996, pp. 205-210

Authors: CATLOW JT BARTON RD CLEMENS M GILLESPIE TA GOODWIN M SWANSON SP
Citation: Jt. Catlow et al., ANALYSIS OF OLANZAPINE IN HUMAN PLASMA UTILIZING REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION, Journal of chromatography B. Biomedical applications, 668(1), 1995, pp. 85-90

Authors: ECKSTEIN JA SWANSON SP
Citation: Ja. Eckstein et Sp. Swanson, DETERMINATION OF A NOVEL PHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONATE RECEPTOR ANTAGONIST (LY300164) AND ITS N-ACETYL METABOLITE IN MOUSE, RAT, DOG, AND MONKEY PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION, Journal of chromatography B. Biomedical applications, 668(1), 1995, pp. 153-158

Authors: JACOBSEN BJ HARLIN KS SWANSON SP LAMBERT RJ BEASLEY VR SINCLAIR JB WEI LS
Citation: Bj. Jacobsen et al., OCCURRENCE OF FUNGI AND MYCOTOXINS ASSOCIATED WITH FIELD MOLD DAMAGEDSOYBEANS IN THE MIDWEST, Plant disease, 79(1), 1995, pp. 86-89

Authors: SWANSON SP CATLOW J POHLAND RC CHAY SH JOHNSON T
Citation: Sp. Swanson et al., DISPOSITION OF THE OPIOID ANTAGONIST, LY255582, IN RATS AND DOGS, Drug metabolism and disposition, 23(9), 1995, pp. 916-921

Authors: FOREMAN MM FULLER RW LEANDER JD BENVENGA MJ WONG DT NELSON DL CALLIGARO DO SWANSON SP LUCOT JB FLAUGH ME
Citation: Mm. Foreman et al., PRECLINICAL STUDIES ON LY228729 - A POTENT AND SELECTIVE SEROTONIN(1A) AGONIST, The Journal of pharmacology and experimental therapeutics, 267(1), 1993, pp. 58-71
Risultati: 1-7 |